Please provide your email address to receive an email when new articles are posted on . In patients with CAD and low EPA:AA ratio on a statin, icosapent ethyl reduced coronary events. CV events were ...

Use of icosapent ethyl (Vascepa), a highly purified eicosapentaenoic acid (EPA), may be associated with a reduction in risk of adverse cardiovascular events in Japanese patients with chronic coronary ...